Registry for Accelerated Partial Breast Irradiation With (SBRT) or (IMRT)

GenesisCare USA

Overview

This is a registry study that will be used to evaluate external beam radiation therapy methods for the accelerated treatment of breast cancer. Patients are being asked to take part in this registry because they have breast cancer and desire treatment with accelerated partial breast irradiation to be delivered by external beam methods.

Study Type

OBSERVATIONAL

Conditions

Breast Cancer

Interventions

Radiation TherapyRADIATION

Either SBRT or IMRT radiation therapy

Eligibility

Sex: FEMALEMin age: 50 YearsMax age: 100 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Greater than or equal to 50 years old Low to intermediate DCIS Tumor size \< or = to 2cm Exclusion Criteria: * BRCA positive Lobular histology Angiolymphatic invasion

Locations (1)

GenesisCare USA

Stuart, Florida, United States

Outcomes

Primary Outcomes

Number of participants with treatment and toxicity-related adverse events as assessed by CTCAE v4.0".

Toxicity will be assessed using the CTCAEv4.0 and recorded.

Time frame: Through study completion, an average of 12 months

Secondary Outcomes

Number of participants with ipsilateral breast recurrence

Number of participants with pathologically confirmed ipsilateral breast recurrence.

Time frame: Through study completion, an average of 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.